American Portfolios Advisors Grifols Sa Transaction History

American Portfolios Advisors

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Mar 20, 2023	BUY	$10.6 - $13.28 $2,575 - $3,227	243 New	243 $2.89 Million
Q3 2021 Mar 22, 2023	BUY	$14.07 - $17.3 $1,603 - $1,972	114 New	114 $1.67 Million
Q2 2021 Mar 22, 2023	BUY	$16.62 - $18.94 $7,828 - $8,920	471 New	471 $8.17 Million
Q1 2021 Mar 22, 2023	BUY	$15.15 - $19.78 $6,893 - $8,999	455 New	455 $7.87 Million
Q4 2020 Mar 22, 2023	BUY	$16.86 - $19.67 $6,339 - $7,395	376 New	376 $6.93 Million
Q3 2020 Mar 22, 2023	BUY	$15.4 - $20.16 $5,790 - $7,580	376 New	376 $6.52 Million
Q1 2020 Mar 24, 2023	BUY	$16.28 - $25.63 $2,197 - $3,460	135 New	135 $2.72 Million
Q4 2019 Mar 24, 2023	BUY	$19.57 - $23.52 $2,974 - $3,575	152 New	152 $3.54 Million
Q3 2019 Mar 24, 2023	BUY	$19.85 - $22.76 $337 - $386	17 Added 12.59%	152 $3.05 Million
Q2 2019 Mar 24, 2023	BUY	$17.59 - $21.1 $2,374 - $2,848	135 New	135 $2.85 Million
Q3 2018 Mar 24, 2023	BUY	$19.97 - $21.96 $2,316 - $2,547	116 New	116 $2.48 Million
Q1 2018 Mar 24, 2023	BUY	$20.31 - $24.95 $2,355 - $2,894	116 New	116 $2.46 Million
Q4 2017 Mar 24, 2023	BUY	$20.99 - $23.89 $1,553 - $1,767	74	74 $1.7 Million

147

151M

2.38M

662K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.57B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.